Vivus' Qnexa phase 3 drug reduces obesity


Vivus (VVUS now trading up 3 to 10) had great results with their obesity drug, Qnexa:

Patients taking Qnexa, on average, reduced their weight by up to 14.7 percent in one trial, while the drug also prompted improvement in blood pressure and diabetes risk factors. A second study showed weight loss of about 13.2 percent. In both studies, patients taking placebo lost less than 3 percent of their weight.

The studies included more than 3,750 patients taking a mix of three doses and placebo.

Vivus said the results support the company's plan to ask for Food and Drug Administration approval by the end of 2009. That could put the company's application ahead of a key competitor, Orexigen Therapeutics Inc.'s Contrave32.
------

Now maybe you won't have to pay a bigger tax on soda pop!

Because Bo came up with this new "sin" tax:
The President, in an interview with Men's Health magazine released yesterday, said he thought taxing soda and other sugary drinks is worth putting on the table as Congress debates health care reform. "It's an idea that we should be exploring," the president said. "There's no doubt that our kids drink way too much soda. And every study that's been done about obesity shows that there is as high a correlation between increased soda consumption and obesity as just about anything else.

Sin taxes on cigarettes, booze, and now soda.

Why doesn't this Administration then tax porn or put a surcharge on adulterous affairs?

What tax is next?

Maybe they'll start throwing extra taxes on Spanx!

Wait---they better not do that.

They might get some supporters!

0 comments:

Post a Comment